21-22 MAY 2021

Brachytherapy: pushing the limits of ablative therapy

Nov. 13, 2020

Nov. 14, 2020

07:30 - 08:00

Breakfast
08:00 - 08:10

Welcome talk

Speaker: Marjory Jolicoeur, MD
08:09 - 11:30
Session I: Breast Cancer

Moderator : Marjory Jolicoeur, MD
At the end of this activity, the participant will be able to

Discuss the techniques of APBI

Evaluate the role of brachytherapy for APBI

Offer 2nd conservative treatment for a recurring breast cancer
Show Objectives
08:10 - 08:40

Session I: Breast

Outcomes of Accelerated Partial Breast Irradiation

Speaker: Frank Vicini, MD

Moderators : Marjory Jolicoeur, MD & Marie Duclos, MD

At the conclusion of this activity, the participant will be able to list the toxicities of this treatment

At the conclusion of this activity, the participant will be able to estimate this treatment's results.

At the conclusion of this activity, the participant will be able to compare cosmetic outcomes of APBI compared to EBRT.

At the conclusion of this activity, the participant will be able to recall GEC-ESTRO and NSABP B39 trial results.

At the conclusion of this activity, the participant will be able to offer APBI as a standard treatment for conservative brest cancer,

Show Objectives
08:40 - 09:00

Session I: Breast

APBI with Brachytherapy

Speaker: Boris Bahoric, MD

At the conclusion of this activity, the participant will be able to determine the different brachytherapy techniques that can be used for APBI

At the conclusion of this activity, the participant will be able to propose different fractionation / schedules for treatment.

At the conclusion of this activity, the participant will be able to recognized the toxicites for eache technique.

At the conclusion of this activity, the participant will be able to list the results of eache technique.

At the conclusion of this activity, the participant will be able to differentiate the particularities of a deep seated tumor.

Show Objectives
09:00 - 09:20

Session I: Breast

APBI before Breast Conservating Surgery

Speaker: Marie Lynn Racine, MD

At the conclusion of this activity, the participant will be able to list the indications of such a treatment

At the conclusion of this activity, the participant will be able to explain the basic principles behind this therapeutic attitude.

At the conclusion of this activity, the participant will be able to propose a target definition

At the conclusion of this activity, the participant will be able to list the toxicities of this technique.

At the conclusion of this activity, the participant will be able to recognize the oncologic and cosmetic outcomes of this treatment.

Show Objectives
09:20 - 09:40

Session I: Breast

Pain Control During Breast Implant

At the conclusion of this activity, the participant will be able to explain the necessity of anesthesia for breast implant.

At the conclusion of this activity, the participant will be able to list the best pain control procedures.

At the conclusion of this activity, the participant will be able to identify the steps involved in a pectoral block.

At the conclusion of this activity, the participant will be able to explain the limitations of paine control in this setting.

Show Objectives
09:40 - 10:00

Session I

Second Conservative Treatment with HDR Brachytherapy for Breast Recurrence

Speaker: Marie Duclos, MD

At the conclusion of this activity, the participant will be able to state the indications of this management.

At the conclusion of this activity, the participant will be able to discuss this treatment alternative with patients

At the conclusion of this activity, the participant will be able to list the parameters to be considered before a second conservative surgery.

At the conclusion of this activity, the participant will be able to recognize the oncologic and cosmetic results of this therapeutic attitude.

Show Objectives
10:00 - 10:20

Coffee Break
10:20 - 10:40

Session I: Breast

Physic's View on APBI: Which Technic for Which Patient?

Speaker: Chrystian Quintero, Physicien médical

At the conclusion of this activity, the participant will be able to discuss the advantages and disadvantages of the following APBI techniques: multicatheter interstitial, intracavitary, intraoperative, EBRT.

At the conclusion of this activity, the participant will be able to compare the dosimetries for each technique

Show Objectives
10:40 - 11:00

Session I: Breast

Radiobiology for APBI: What do we know?

Speaker: Alvaro Martinez, MD

At the conclusion of this activity, the participant will be able to discuss the α/β ratio for breast cancer

At the conclusion of this activity, the participant will be able to compare outcomes for different fractionation schedules

At the conclusion of this activity, the participant will be able to discuss the limitation of the α/β ratio

Show Objectives
11:10 - 11:30

Session I: Breast

Breast Brachytherapy cases: Interactive session

Speakers: Boris Bahoric, MD & Frank Vicini, MD

At the end of this activity, the participant will be able to identify the indication for brachytherapy in each case

At the end of this activity, the participant will be able to illustrate the implant technique

At the end of this activity, the participant will be able to propose a dose prescription and a fractionation schedule

At the end of this activity, the participant will be able to discuss the cosmetic outcomes of brachytherapy

Show Objectives

11:30 - 12:20

Mini Workshops Part I

Each workshop lasts 40 minutes. Each participant may take up to 2 workshops. The breast implant workshop is given in 2 parts. If you take it in the morning, you have to continue with the second part in the afternoon.

Hands on Breast Implant, part 1
At the end of this activity, the participant will be able to: Discuss pre-brachetherapy imaging Evaluate the feasability of the implant Discriminate between applicator or a multicatheter implant	Marjory Jolicoeur & Dany Truchon
Hands on Prostate Implant
At the end of this activity, the participant will be able to Analyze the needle placement for an optimal dosimetry	Alvaro Martinez
Contours and Dosimetry for Prostate Cancer
At the end of this activity, the participant will be able to Discuss the imaging for the implant and the dosimetry Discuss the benefit of a DIL boost Analyze the IPSA dosimetry and its weaknesses	Talar Derashodian & Andre-Guy Martin
Liver Brachythrapy
At the end of this activity, the participant will be able to Discriminate between the different available applicators Discuss dosimetry Analyze the feasability of the implant	Stefanie Corradini

12:20 - 13:50

Lunch and poster viewing
13:50 - 14:10

Session II: Aging and Brachytherapy

Influence of age on Brachytherapy Outcome

Speaker: Talar Derashodian, MD

At the end of this activity, the participant will be able to discuss the difference of sensivity and tolerance of tissues in the aging patient.

At the end of this activity, the participant will be able to interpret the available literature.

Show Objectives
14:10 - 14:30

Session II: Aging and Brachytherapy

Can a patient be too old for brachytherapy

Speaker: Flavia De Angelis, MD

At the end of this activity, the participant will be able to evaluate the geriatric patient for the procedure

At the end of this activity, the participant will be able to describe the steps necessary to get the aging patient through the process,

Show Objectives
14:30 - 14:50

Session II: Aging and Brachytherapy

Influence of Age on Brachytherapy Outcomes: Interactive Session

Speaker: Flavia De Angelis, MD

At the end of this activity, the participant will be able to propose therapeutic options respecting the patient's age and clinical status

At the end of this activity, the participant will be able to determine if the radiobiology in an aging patient is different from a younger patient,

Show Objectives
14:50 - 15:30

Coffee Break and poster viewing
15:29 - 17:59

Session III: Young investigators

Session III ; Young investigators

Moderator : Cynthia Ménard, MD
15:30 - 16:30

Session III: Young investigators

Oral presentations

15:30 7-24 TBD

TBD

15:40 7-20 TBD

TBD

15:50 7-23 TBD

TBD

16:00 7-15 TBD

TBD

Show Objectives

16:30 - 17:10

Mini Workshops Part II

Hands on Breast Implant, part 1
At the end of this activity, the participant will be able to: Contour the breast CTV Perform catheter reconstruction and dosimetry Analyze the pros and cons of this technique	Marjory Jolicoeur & Dany Truchon
Hands on Prostate Implant
At the end of this activity, the participant will be able to Analyze the needle placement for an optimal dosimetry	Alvaro Martinez
Contours and Dosimetry for Prostate Cancer
At the end of this activity, the participant will be able to Discuss the imaging for the implant and the dosimetry Discuss the benefit of a DIL boost Analyze the IPSA dosimetry and its weaknesses	Talar Derashodian & Andre-Guy Martin
Bladder Brachythrapy
At the end of this activity, the participant will be able to Discriminate between the different available applicators Discuss dosimetry Analyze the feasability of the implant	Bradley Pieters

18:30 - 22:00

Dinner

07:30 - 08:00

Breakfast
07:59 - 09:00

Session IV: Gyn

Moderators : Anne Sophie Gauthier Paré, MD & Eric Leung, MD
08:00 - 08:05

Opening

Speaker: Marjory Jolicoeur, MD
08:00 - 08:20

Section IV Gyn

Brachytherapy for vaginal cancer

Speaker: Lucas Mendez, MD

At the conclusion of this activity, the participant will be able to interpret the available literature

At the conclusion of this activity, the participant will be able to list the indications and benefits of this treatment

At the conclusion of this activity, the participant will be able to explain the outcomes of this treatment

At the conclusion of this activity, the participant will be able to list GEC-ESTRO recommendations

At the conclusion of this activity, the participant will be able to choose between endocavitary, interstitial or both brachytherapy techniques

Show Objectives
08:20 - 08:40

Section IV Gyn

Image guided HDR Brachytherapy for vaginal cancer

Speaker: Aman Taggar, MD

At the conclusion of this activity, the participant will be able to identify the indications and benefits of an image-guided implant

At the conclusion of this activity, the participant will be able to master the needle placement in interstitial brachytherapy

At the conclusion of this activity, the participant will be able to comprehend adaptive treamtment

Show Objectives
08:40 - 09:00

Section IV Gyn

Difficult Implants of Cervical Cancers

Speakers: Joanne Alfieri, MD & Alvaro Martinez, MD

Three cases will be discussed

At the conclusion of this activity, the participant will be able to indentify the need for endocavitary and interstitial brachytherapy

At the conclusion of this activity, the participant will be able to assess hard to reach areas

At the conclusion of this activity, the participant will be able to perform the needed adjustments for needle placement in hard to reach areas

Show Objectives
08:59 - 10:00

Session IV ; Physic's Corner

Moderators : Sandrine David, Physicienne médical & Shirin Enger, Physicienne médical
09:00 - 09:20

Session V: Physic's corner

Inverse Treatment Planning in Brachytherapy

Speaker: Luc Beaulieu, Physicien médical

At the end of this activity, the participant will be able to explain the basic principles of automatic dose optimization.

At the end of this activity, the participant will be able to explain the different algorithms used.

At the end of this activity, the participant will be able to illustrate the use of inverse planning brachytherapy for different tumoral sites.

At the end of this activity, the participant will be able to identify the optimal use and advantages on inverse planning in brachytherapy.

Show Objectives
09:20 - 09:40

Session V: Physic's corner

What is the future of inverse planning?

Speaker: Christopher Deufel, Physicien médical

At the conclusion of this activity, the participant will be able to explain the need for manual adjustments to an inversely optimized plan.

At the conclusion of this activity, the participant will be able to identify the possible use of AI in inverse planning.

At the conclusion of this activity, the participant will be able to explain the principles of automation and inverse planning.

Show Objectives
09:40 - 10:00

Session V: Physic's corner

HDR Prostate Dosimetry: Is The Solution Related to the Implant or to the Physicit

Speaker: Dany Truchon, Physicien médical

At the conclusion of this activity, the participant will be able to explain the dosimetric criteria used in the BRP2 protocole

At the conclusion of this activity, the participant will be able to illustraite the need of 2 dosimetries for 2 different fractions in a single implant

Show Objectives
10:00 - 10:30

Coffee break
10:29 - 12:00

Session V1: Miscellaneous indications of brachytherapy

Session VI: Miscellaneous Indications of Brachytherapy

Moderator : Thu Van Nguyen, MD
10:30 - 11:00

Session IV: Other indications of brachytherapy

Brachytherapy for Penile Cancer

Speaker: Mira Keyes, MD

At the end of this activity, the participant will be able to analyze the available literature.

At the end of this activity, the participant will be able to list the indications for penile brachytherapy.

At the end of this activity, the participant will be able to discuss the technical aspects of this treatment.

At the end of this activity, the participant will be able to discuss the oncologic and functional outcomes of this technique,

Show Objectives
11:00 - 11:30

Session IV: Other indications of brachytherapy

Interstitial Brachytherapy for Bladder Cancer

Speaker: Bradley Pieters, MD

At the end of this activity, the participant will be able to discuss the available literature.

At the end of this activity, the participant will be able to discuss the technical aspects of this procedure.

At the end of this activity, the participant will be able to list the indications of the procedure.

At the end of this activity, the participant will be able to recognize the oncologic and functional outcomes of thise procedure.

Show Objectives
11:30 - 12:00

Session IV: Other indications of brachytherapy

Insterstitial HDR Brachytherapy for Liver Tumors

Speaker: Stefanie Corradini, MD

At the end of this activity, the participant will be able to discuss the technical aspects of this procedure.

At the end of this activity, the participant will be able to list the indications for hepatocellular carcinoma

At the end of this activity, the participant will be able to list the indications for liver metastasis

At the end of this activity, the participant will be able to compare the dosimetries between brachytherapy and SBRT

At the end of this activity, the participant will be able to discuss the oncologic and functional outcomes of this procedure.

Show Objectives
12:00 - 13:10

Lunch Break
13:09 - 14:50

Session VII: Prostate cancer

Session VII: Prostate Cancer
13:10 - 13:30

Session VII: Prostate cancer

Long Term outcomes of the HDR brachytherapy boost

Speaker: André-Guy Martin, MD

At the conclusion of this activity, the participant will be able to list the indications of this treatment

At the conclusion of this activity, the participant will be able to plan a follow-up schedule for these patients

At the conclusion of this activity, the participant will be able to comprehend the increased use of this technique

Show Objectives
13:30 - 13:50

Session VII: Prostate cancer

Prostate Monotherapy: Outcomes of the Single Fraction Regimens

Speaker: Alfonso Gomez-Iturriaga, MD

At the conclusion of this activity, the participant will be able to interpret the available literature

At the conclusion of this activity, the participant will be able to discuss the different dose and fractionation regimens

At the conclusion of this activity, the participant will be able to discuss the outcomes of the single fractions regiments.

Show Objectives
13:50 - 14:10

Session VII: Prostate cancer

What is the Problem with the One Fraction Monotherapy

Speaker: Peter Chung, MD

At the conclusion of this activity, the participant will be able to summarize the variability of monotherapy regimens

At the conclusion of this activity, the participant will be able to analyze normal tissue reaction to a single dose schedule

At the conclusion of this activity, the participant will be able to theorize a radiobiological explanation for the single fractions failure rates

At the conclusion of this activity, the participant will be able to comprehend the cell cycle progression markers targeted by radiotherapy

Show Objectives
14:10 - 14:30

Session VII: Prostate cancer

Long Term side effects of HDR Brachytherapy for localised Prostate Cancer

Speaker: Alvaro Martinez, MD

At the conclusion of this activity, the participant will be able to recognize urethral strictures, and their incidence in brachytherapy patients

At the conclusion of this activity, the participant will be able to explain the predictive value of the brachytherapy dose to the tumor and to normal tissues

At the conclusion of this activity, the participant will be able to explain the predictive value of the implant technique

At the conclusion of this activity, the participant will be able to anlayze a dosimetry

Show Objectives
14:30 - 14:50

Session VII: Prostate cancer

Focal HDR Brachytherapy

Speaker: Marisa A Kollmeier, MD

At the conclusion of this activity, the participant will be able to analyze the available literature

At the conclusion of this activity, the participant will be able to list the indications for this treatment

At the conclusion of this activity, the participant will be able to choose a dose fractionation

At the conclusion of this activity, the participant will be able to discuss the toxicities of this treatment

Show Objectives
14:50 - 15:20

Coffee Break
15:20 - 15:30

Session VII: Prostate cancer

HDR Brachytherapy for Local recurrence

Speaker: Cynthia Ménard, MD

At the conclusion of this activity, the participant will be able to analyze the available literature

At the conclusion of this activity, the participant will be able to list the indications for this treatment

At the conclusion of this activity, the participant will be able to choose a dose fractionation

At the conclusion of this activity, the participant will be able to discuss the toxicities of this treatment

Show Objectives
15:29 - 18:00

Session VIII: Debates

Session VIII: Debates
15:30 - 15:45

Session VIII: Debates
HDR Monotherapy: Single vs Multiple Fractions

Speakers: Alvaro Martinez, MD & Alfonso Gomez-Iturriaga, MD
Referee: Marjory Jolicoeur

Single Fraction: Alvaro Martinez

Multiples Fractions: Gomez Iturriaga

At the end of this activity, the participant will be able to:

Discriminate between a single or multiple fractions for HDR monotherapy in prostate cancer

Explain the advantages and disadvantages of each

Choose the optimal treament for a given patient
Show Objectives
15:45 - 16:00

Session VIII: Debates
Debate: HDR Monotherapy vs SABR

Speakers: André-Guy Martin, MD & Cynthia Ménard, MD
Referee: Alvaro Martinez

Pro HDR:André-Guy Martin

Pro SABR: Cynthia Ménard

At the end of this activity, the participant will be able to:

List the advantages and disadvantaes of each treatment technique

Choose the optimal treatment technique for a given patient
Show Objectives
16:00 - 17:50

Session VIII: Debates

Plenary Session

Moderator : Marjory Jolicoeur, MD

The participants will be able to interact with the experts on the different subjects presented during the past 2 days.

Show Objectives

15:30	7-24	TBD
		TBD
15:40	7-20	TBD
		TBD
15:50	7-23	TBD
		TBD
16:00	7-15	TBD
		TBD

Brachytherapy: pushing the limits of ablative therapy

07:30 - 08:00

Breakfast

08:00 - 08:10

Welcome talk

08:09 - 11:30

Session I: Breast Cancer

08:10 - 08:40

Session I: Breast

Outcomes of Accelerated Partial Breast Irradiation

08:40 - 09:00

Session I: Breast

APBI with Brachytherapy

09:00 - 09:20

Session I: Breast

APBI before Breast Conservating Surgery

09:20 - 09:40

Session I: Breast

Pain Control During Breast Implant

09:40 - 10:00

Session I

Second Conservative Treatment with HDR Brachytherapy for Breast Recurrence

10:00 - 10:20

Coffee Break

10:20 - 10:40

Session I: Breast

Physic's View on APBI: Which Technic for Which Patient?

10:40 - 11:00

Session I: Breast

Radiobiology for APBI: What do we know?

11:10 - 11:30

Session I: Breast

Breast Brachytherapy cases: Interactive session

11:30 - 12:20

Mini Workshops Part I

12:20 - 13:50

Lunch and poster viewing

13:50 - 14:10

Session II: Aging and Brachytherapy

Influence of age on Brachytherapy Outcome

14:10 - 14:30

Session II: Aging and Brachytherapy

Can a patient be too old for brachytherapy

14:30 - 14:50

Session II: Aging and Brachytherapy

Influence of Age on Brachytherapy Outcomes: Interactive Session

14:50 - 15:30

Coffee Break and poster viewing

15:29 - 17:59

Session III: Young investigators

Session III ; Young investigators

15:30 - 16:30

Session III: Young investigators

Oral presentations

16:30 - 17:10

Mini Workshops Part II

18:30 - 22:00

Dinner

07:30 - 08:00

Breakfast

07:59 - 09:00

Session IV: Gyn

08:00 - 08:05

Opening

08:00 - 08:20

Section IV Gyn

Brachytherapy for vaginal cancer

08:20 - 08:40

Section IV Gyn

Image guided HDR Brachytherapy for vaginal cancer

08:40 - 09:00

Section IV Gyn

Difficult Implants of Cervical Cancers

08:59 - 10:00

Session IV ; Physic's Corner

09:00 - 09:20

Session V: Physic's corner

Inverse Treatment Planning in Brachytherapy

09:20 - 09:40

Session V: Physic's corner